Laurus Labs Ltd.’s proposed generic version of Complera infringes three patents for the HIV treatment, two a Johnson & Johnson unit licenses to Gilead Sciences Inc. and a third they own jointly, a ...

"Where is PNG headed? If the government continues down this path, it risks trading democracy for control." Many social media users, however, appeared to outdo the government, with many downloading and ...